Matthew Gilbert Oser

Dana-Farber Cancer Inst

$2,847,213

Attributed

$2,847,213

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,847,213 · 3

By mechanism

R37$1,367,119 · 1

K08$885,600 · 1

P01$594,494 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Donald W. Kufe$50,160,456
Nathanael Schiander Gray$36,761,550
Michael J Eck$25,871,961
Bruce E. Johnson$13,594,149
David A Barbie$12,794,638

Others in their field

Other Emerging Leaders on “In Vitro”

Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
Tony Moody · Duke University$34,777,314

Research focus

In VitroClustered Regularly Interspaced Short Palindromic RepeatsTumor InitiationIn VivoGenetically Engineered MouseGenesGeneticRepressionTargeted TreatmentCancer Cell LineTumorNeuroendocrine DifferentiationBindingAscl1 GeneNeuroendocrine PhenotypeNeuroendocrine TumorsCancer PatientClinical TrialsNeurosecretory SystemsLaboratoriesPre-ClinicalLoss Of FunctionHistone DemethylaseInsight